- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Can NeoVista’s Epimacular Brachytherapy Improve Treatment of Macular Degeneration?

Posted By Dr. Ari Weitzner On October 17, 2010 @ 2:01 am In Macular Degeneration,New Technologies,Retina | Comments Disabled

At the American Academy of Ophthalmology meeting, NeoVista made public the one-year results from their MERITAGE Study. This study was designed to examine NeoVista’s Epimacular Brachytherapy procedure when used in patients who require chronic therapy with anti-VEGF agents on an ongoing basis to control Neovascular Age-Related Macular Degeneration (Wet AMD).

Study results to date suggest that a single procedure of Epimacular Brachytherapy can stabilize visual acuity in a majority of wet AMD patients (79%) while decreasing the number of anti-VEGF injections required. Most
importantly, 47% of patients enrolled in the study experienced some improvement in their visual acuity while 10% of patients gained 15 or more letters of visual acuity at 12 months. This improvement is significant in patients that had been receiving chronic anti-VEGF treatment with no vision improvement in the year prior to enrollment.

Read [1] the full release.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/004142-can-neovistas-epimacular-brachytherapy-improve-treatment-of-macular-degeneration/

URLs in this post:

[1] Read: http://www.neovistainc.com/docs/MERITAGE-12-Month-Press-Release.pdf

Copyright © 2008 Eye Doc Talk. All rights reserved.